Stem cell transplants from unrelated donors do well in myeloma study

03/30/2012 | MyelomaBeacon.com

A French study published in the European Journal of Hematology found that nonmyeloablative donor stem cell transplant from unrelated donors can benefit patients with multiple myeloma. The procedure employs lower doses of chemotherapy and radiation than standard methods. Overall and progression-free survival rates were close for patients who received stem cells from a related donor and those who received stem cells from an unrelated donor.

View Full Article in:

MyelomaBeacon.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC